F-star is a clinical-stage biopharmaceutical company committed to delivering life-changing treatments to cancer patients. Through our highly efficient Modular Antibody Technology™ platform, we are building and progressing an extensive immuno-oncology pipeline of mAb²™, a novel class of disruptive bispecific antibodies designed to unlock new biology which cannot be achieved by combining monospecific drugs.
F-star is a clinical-stage biopharmaceutical company committed to delivering life-changing treatments to cancer patients. Through our highly efficient Modular Antibody Technology™ platform, we are building and progressing an extensive immuno-oncology pipeline of mAb²™, a novel class of disruptive bispecific antibodies designed to unlock new biology which cannot be achieved by combining monospecific drugs.
Your career starts on Magnet.me
Create a profile and receive connection requests from interested companies.
This company page was generated automatically and therefore features only limited information. Find out more about F-Star UK on their company website:
This company page was generated automatically and therefore features only limited information. Find out more about F-Star UK on their company website:
Change language to: Dutch
This page is optimised for people from the Netherlands. View the version optimised for people from the UK.